Target intelligence / Profile preview

Hepatocyte RNA polymerase II (RNAP II)

Target
RNAP II
Molecular classification
Enzyme, Transferase, RNA polymerase
01

Overview

The hepatocyte protein and rRNA synthesis machinery, primarily centered around RNA polymerase II, is the fundamental cellular apparatus responsible for transcribing DNA into messenger RNA (mRNA), which subsequently serves as the template for protein synthesis. In the liver, this machinery is critical for maintaining metabolic homeostasis, producing plasma proteins, and detoxifying endogenous and exogenous compounds. This system is a primary target for potent hepatotoxins such as alpha-amanitin, which binds specifically to RNA polymerase II, halting the production of mRNA and leading to rapid centrilobular hepatic necrosis. Because hepatocytes actively take up certain toxins via organic anion transporting polypeptides (OATPs), this machinery becomes a focal point of toxicity in poisoning cases. Beyond toxicology, components of this machinery are explored as therapeutic targets in oncology, where inhibiting transcription can selectively induce apoptosis in rapidly dividing cancer cells.

Other names
DNA-directed RNA polymerase IIRNA polymerase BHepatocyte protein synthesis machineryNucleolar rRNA synthesis apparatus
02

Mechanism of action

Inhibition of DNA-directed RNA polymerase II leads to the cessation of messenger RNA (mRNA) synthesis. This prevents the translation of essential proteins, resulting in cellular atrophy and apoptotic cell death, particularly in hepatocytes where certain toxins are actively sequestered.

03

Biological functions

TranscriptionmRNA synthesisProtein synthesis regulationCellular homeostasisGene expression
04

Disease associations

Liver failureHepatotoxicityAmanita phalloides poisoningCancer
05

Safety considerations

Severe hepatotoxicityAcute liver failureNephrotoxicityNarrow therapeutic index for systemic inhibitors
06

Interacting drugs

Alpha-amanitin

3 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)BilirubinProthrombin time

Beyond the preview

Go deeper on Hepatocyte RNA polymerase II (RNAP II).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte RNA polymerase II (RNAP II).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call